Odette Cancer Centre

Futó vizsgálatok

• Toboroz

  LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma

  NCT06623461· 2. fázis· Forrás

• Toboroz

  Palliative Steroeotactic Body Radiotherapy vs Palliative Standard Radiotherapy in Patients With Advanced Head and Neck Cancer

  NCT06641791· 3. fázis· Forrás

• Toboroz

  Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes

  NCT06439225· 3. fázis· Forrás

• Toboroz

  Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

  NCT05640999· 2. fázis· Forrás

• Toboroz

  Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer

  NCT04918186· 2. fázis· Forrás

• Fut, nem toboroz

  177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer

  NCT04663997· 2. fázis· Forrás

• Toboroz

  Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.

  NCT03061435· Forrás

• Fut, nem toboroz

  Intermittent Androgen Deprivation Therapy With or Without Stereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive Oligometastatic Prostate Cancer

  NCT04619069· 1/2. fázis· Forrás

• Fut, nem toboroz

  Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer

  NCT03784755· Forrás

• Fut, nem toboroz

  De-Escalation Radiotherapy in Patients With Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma

  NCT03822897· 2. fázis· Forrás

• Fut, nem toboroz

  CFI-400945 in Patients With Advanced/Metastatic Breast Cancer

  NCT03624543· 2. fázis· Forrás

• Fut, nem toboroz

  Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer

  NCT02905318· 2. fázis· Forrás

• Fut, nem toboroz

  Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer

  NCT02960087· Forrás

• Toboroz

  Duration of Anti-PD-1 Therapy in Metastatic Melanoma

  NCT02821013· 3. fázis· Forrás

• Toboroz

  Stereotactic Ablative Radiation Therapy for Abiraterone-Resistant, Oligoprogressive Metastatic Prostate Cancer

  NCT04838899· Forrás

• Fut, nem toboroz

  Prostate Advances in Comparative Evidence

  NCT01584258· 3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Melanóma2 toboroz
• Prosztatarák2 toboroz
• Fej-nyaki daganatok1 toboroz
• Méhnyakrák1 toboroz
• Méhtestrák1 toboroz
• Petefészekrák1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure

  NCT04442048· 3. fázis· Forrás

• Lezárult

  Durvalumab With or Without Tremelimumab in Metastatic Castration Resistant Prostate Cancer

  NCT02788773· 2. fázis· Forrás

• Lezárult

  Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC

  NCT02273375· 3. fázis· Forrás

• Lezárult

  Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer

  NCT00819208· Forrás